Document

EX-99.1 2 epr06302023.htm EX-99.1 Document

Bunge Reports Second Quarter 2023 Results

St. Louis, MO - August 2, 2023 - Bunge Limited (NYSE: BG) today reported second quarter 2023 results

•Q2 GAAP diluted EPS of $4.09 vs. $1.34 in the prior year; $3.72 vs. $2.97 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences

•Agribusiness results driven by strong execution throughout the value chains

•Strong Refined and Specialty Oils performance in line with last year

•Accelerated strategy with agreement to combine with Viterra

•Increasing full-year adjusted EPS outlook to at least $11.75 per share


Ø			Overview

Greg Heckman, Bunge’s Chief Executive Officer, commented, “We delivered strong results as we successfully navigated a highly dynamic quarter through agility and discipline, capturing opportunities while continuing to serve our customers at both ends of the value chain. Our team remained flexible, leveraging our global footprint and connectivity to optimize margins and utilization as market conditions evolved over the quarter.

“We look forward to our announced combination with Viterra, which will accelerate our strategy to bring us even closer to farmers with expanded direct origination, while also broadening our global processing and distribution network to better serve our consuming customers. We continue to execute on our strategic priorities, with a focus on driving further adoption of sustainable practices in global food, feed and fuel production including low-carbon product streams, regenerative agriculture, and end-to-end traceability across major crops. With enhanced capabilities, a world-class team and a strong balance sheet, we are well positioned to create value for all our stakeholders.”


Ø			Financial Highlights


	Three Months Ended June 30,				Six Months Ended June 30,
(US$ in millions, except per share data)	2023		2022		2023		2022
Net income attributable to Bunge	$	622	$	206	$	1,254	$	894
Net income per common share-diluted	$	4.09	$	1.34	$	8.24	$	5.81

Mark-to-market timing differences (a)	$	(0.59)	$	1.26	$	(1.43)	$	0.87
Certain (gains) & charges (b)	$	0.22	$	0.37	$	0.17	$	0.55


Adjusted Net income per common share-diluted (c)	$	3.72	$	2.97	$	6.98	$	7.23

Core Segment EBIT (c) (d)	$	1,016	$	408	$	1,963	$	1,330
Mark-to-market timing differences (a)	(114)		233		(295)		157
Certain (gains) & charges (b)	(9)		68		(19)		80
Adjusted Core Segment EBIT (c)	$	893	$	709	$	1,649	$	1,567

Corporate and Other EBIT (c)	$	(155)	$	(92)	$	(235)	$	(155)
Certain (gains) & charges (b)	34		—		34		(29)
Adjusted Corporate and Other EBIT (c)	$	(121)	$	(92)	$	(201)	$	(184)

Non-core Segment EBIT (c) (e)	$	51	$	6	$	70	$	40
Certain (gains) & charges (b)	—		—		—		—
Adjusted Non-core Segment EBIT (c)	$	51	$	6	$	70	$	40

Total Segment EBIT (c)	$	912	$	322	$	1,798	$	1,215
Mark-to-market timing differences (a)	(114)		233		(295)		157
Certain (gains) & charges (b)	25		68		15		51
Adjusted Total Segment EBIT (c)	$	823	$	623	$	1,518	$	1,423

(a)Mark-to-market timing impact of certain commodity and freight contracts, readily marketable inventories, and related hedges associated with committed future operating capacity. See note 3 in the Additional Financial information section of this release for details.

(b)Certain (gains) & charges included in Total Segment EBIT. See Additional Financial Information for details.

(c)Core Segment EBIT, Adjusted Core Segment EBIT, Corporate and Other EBIT, Adjusted Corporate and Other EBIT, Non-core Segment EBIT, Adjusted Non-core Segment EBIT, Total Segment EBIT, Adjusted Total Segment EBIT, and Adjusted Net income per common share-diluted are non-GAAP financial measures. Reconciliations to the most directly comparable U.S. GAAP measures are included in the tables attached to this press release and the accompanying slide presentation posted on Bunge's website.

(d)Core Segment earnings before interest and tax ("Core Segment EBIT") comprises the aggregate earnings before interest and tax (“EBIT”) of Bunge’s Agribusiness, Refined and Specialty Oils and Milling reportable segments, and excludes Bunge's Sugar & Bioenergy reportable segment and Corporate and Other activities.

(e)Non-core Segment EBIT comprises Bunge’s Sugar & Bioenergy reportable segment EBIT, which reflects Bunge's share of the results of its 50/50 joint venture with BP p.l.c.


Ø			Second Quarter Results

Core Segments

Agribusiness


	Three Months Ended				Six Months Ended
(US$ in millions, except per share data)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Volumes (in thousand metric tons)	18,257		19,490		36,643		39,560

Net Sales	$	10,875	$	12,747	$	21,727	$	23,978

Gross Profit	$	997	$	316	$	1,805	$	1,180

Selling, general and administrative expense	$	(151)	$	(119)	$	(283)	$	(240)

Foreign exchange gains (losses)	$	(64)	$	(93)	$	(25)	$	(84)

EBIT attributable to noncontrolling interests	$	1	$	(13)	$	(20)	$	(17)

Other income (expense) - net	$	7	$	(14)	$	18	$	(77)

Income (loss) from affiliates	$	(5)	$	16	$	(5)	$	30

Segment EBIT	$	785	$	93	$	1,490	$	792
Mark-to-market timing differences	(102)		224		(285)		141
Certain (gains) & charges	(9)		69		(19)		80
Adjusted Segment EBIT	$	674	$	386	$	1,186	$	1,013

Certain (gains) & charges, Net income (loss) attributable to Bunge	$	(8)	$	59	$	(16)	$	68
Certain (gains) & charges, Earnings per share	$	(0.06)	$	0.38	$	(0.11)	$	0.44

Processing (2)


	Three Months Ended				Six Months Ended
(US$ in millions)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Processing EBIT	$	586	$	11	$	1,223	$	562
Mark-to-market timing differences	(56)		175		(279)		77
Certain (gains) & charges	(4)		44		(14)		52
Adjusted Processing EBIT	$	526	$	230	$	930	$	691

Higher results in the quarter were primarily driven by softseed crush and strong Brazil soybean origination which also contributed to higher crush results in Brazil and our destination crush operations in Europe and Asia. Results in the US were also higher than last year.

Merchandising (2)


	Three Months Ended				Six Months Ended
(US$ in millions)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Merchandising EBIT	$	199	$	82	$	267	$	230
Mark-to-market timing differences	(46)		49		(6)		64
Certain (gains) & charges	(5)		25		(5)		28
Adjusted Merchandising EBIT	$	148	$	156	$	256	$	322

Higher results in global oils and grains were more than offset by lower results in our financial services and ocean freight operations, which had difficult comparisons to a particularly strong prior year.

Refined & Specialty Oils


	Three Months Ended				Six Months Ended
(US$ in millions, except per share data)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Volumes (in thousand metric tons)	2,212		2,328		4,358		4,624

Net Sales	$	3,601	$	4,445	$	7,489	$	8,421

Gross Profit	$	333	$	325	$	675	$	587

Selling, general and administrative expense	$	(98)	$	(87)	$	(193)	$	(176)

Foreign exchange gains (losses)	$	5	$	(8)	$	10	$	(8)

EBIT attributable to noncontrolling interests	$	(7)	$	(7)	$	(11)	$	(4)

Other income (expense) - net	$	(16)	$	(5)	$	(31)	$	(8)



Segment EBIT	$	217	$	218	$	450	$	391
Mark-to-market timing differences	(10)		(3)		(9)		3
Certain (gains) & charges	—		(1)		—		—
Adjusted Segment EBIT	$	207	$	214	$	441	$	394

Certain (gains) & charges, Net income (loss) attributable to Bunge	$	—	$	(1)	$	—	$	—
Certain (gains) & charges, Earnings per share	$	—	$	(0.01)	$	—	$	—

Refined & Specialty Oils Summary

Higher results in North America driven by food service and fuel demand were offset by slightly lower results in Europe, South America and Asia.

Milling


	Three Months Ended				Six Months Ended
(US$ in millions, except per share data)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Volumes (in thousand metric tons)	844		1,143		1,665		2,304

Net Sales	$	490	$	677	$	1,005	$	1,280

Gross Profit	$	40	$	126	$	71	$	197

Selling, general and administrative expense	$	(24)	$	(28)	$	(45)	$	(52)

Foreign exchange gains (losses)	$	(1)	$	—	$	(1)	$	3



Other income (expense) - net	$	(2)	$	—	$	(3)	$	—

Segment EBIT	$	14	$	97	$	23	$	147
Mark-to-market timing differences	(2)		12		(1)		13
Certain (gains) & charges	—		—		—		—
Adjusted Segment EBIT	$	12	$	109	$	22	$	160

Certain (gains) & charges, Net income (loss) attributable to Bunge	$	—	$	—	$	—	$	—
Certain (gains) & charges, Earnings per share	$	—	$	—	$	—	$	—

Milling Summary

Lower results in the quarter were primarily driven by our South American operations which were negatively impacted by the small Argentine wheat crop. Segment results in the prior year benefited from effective risk management of our supply chains during a period of high market volatility.

Corporate and Other


	Three Months Ended				Six Months Ended
(US$ in millions, except per share data)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Gross Profit	$	(7)	$	3	$	(7)	$	8

Selling, general and administrative expense	$	(147)	$	(100)	$	(252)	$	(174)

Foreign exchange gains (losses)	$	(6)	$	(9)	$	(1)	$	(9)

EBIT attributable to noncontrolling interests	$	1	$	1	$	1	$	(11)

Other income (expense) - net	$	21	$	13	$	41	$	32

Income (loss) from affiliates	$	(17)	$	—	$	(17)	$	(1)

Segment EBIT	$	(155)	$	(92)	$	(235)	$	(155)
Certain (gains) & charges	34		—		34		(29)
Adjusted Segment EBIT	$	(121)	$	(92)	$	(201)	$	(184)

Certain (gains) & charges, Net income (loss) attributable to Bunge	$	42	$	—	$	42	$	18
Certain (gains) & charges, Earnings per share	$	0.28	$	—	$	0.28	$	0.11

Corporate


	Three Months Ended				Six Months Ended
(US$ in millions)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Corporate EBIT	$	(139)	$	(112)	$	(226)	$	(158)
Certain (gains) & charges	18		—		18		(29)
Adjusted Corporate EBIT	$	(121)	$	(112)	$	(208)	$	(187)

Other


	Three Months Ended				Six Months Ended
(US$ in millions)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022
Other EBIT	$	(16)	$	20	$	(9)	$	3
Certain (gains) & charges	16		—		16		—
Adjusted Other EBIT	$	—	$	20	$	7	$	3

Corporate and Other Summary

The increase in Corporate expenses in the quarter primarily reflected investments in growth and productivity-related initiatives. Lower Other results related to our captive insurance program and Bunge Ventures.

Non-core Segments

Sugar & Bioenergy


	Three Months Ended				Six Months Ended
(US$ in millions, except per share data)	Jun 30, 2023		Jun 30, 2022		Jun 30, 2023		Jun 30, 2022


Net Sales	$	72	$	57	$	136	$	121

Gross Profit	$	2	$	2	$	2	$	4





Income (loss) from affiliates	$	47	$	4	$	66	$	36

Segment EBIT	$	51	$	6	$	70	$	40
Certain (gains) & charges	—		—		—		—
Adjusted Segment EBIT	$	51	$	6	$	70	$	40

Certain (gains) & charges, Net income (loss) attributable to Bunge	$	—	$	—	$	—	$	—
Certain (gains) & charges, Earnings per share	$	—	$	—	$	—	$	—

Sugar & Bioenergy Summary

Results included a $39 million benefit from the reversal of a valuation allowance. In addition, improved results reflect higher sugar prices that more than offset lower ethanol prices.

Cash Flow


	Six Months Ended
	Jun 30, 2023		Jun 30, 2022
Cash provided by (used for) operating activities	$	472	$	(4,457)
Proceeds from beneficial interest in securitized trade receivables (a)	79		3,311
Cash provided by (used for) operating activities, adjusted	$	551	$	(1,146)
Certain reconciling items to Adjusted funds from operations (4)	809		2,385
Adjusted funds from operations (4)	$	1,360	$	1,239

(a)On November 16, 2022, Bunge and certain of its subsidiaries amended its trade receivables securitization program from a deferred purchase price ("DPP") structure to a pledge structure. Prior to November 16, 2022, Bunge received a portion of its consideration in the form of beneficial interests in securitized trade receivables. Cash collections of the beneficial interests were classified as investing activities in the consolidated statements of cash flows. Subsequent to November 16, 2022, all consideration is received in cash and classified as an operating activity in the consolidated statements of cash flows, except for transition-related collections of repurchased receivables which are reported as investing activity in Proceeds from beneficial interest in securitized trade receivables in the consolidated statements of cash flows.

Cash provided by operations in the six months ended June 30, 2023, was $472 million compared to cash used of $4,457 million in the same period last year. Adjusted for the proceeds from beneficial interest in securitized trade receivables, cash provided by operating activities was $551 million compared with cash used for operating activities of $1,146 million in the prior year. The higher cash provided by operating activities, adjusted, was primarily driven by net changes in working capital and higher reported net income. Adjusted funds from operations (FFO) was $1,360 million compared to $1,239 million in the prior year.(4)

Income Taxes

For the six months ended June 30, 2023, income tax expense was $381 million compared to $144 million in the prior year. The increase was primarily due to higher pre-tax income in 2023 as well as a change in geographic earnings mix.


Ø			Outlook(5)

Taking into account first half of the year results and the current margin environment and forward curves, we now expect full-year 2023 adjusted EPS of at least $11.75 per share with potential upside depending on how market conditions evolve over the remainder of the year.

In Agribusiness, full-year results are expected to be up slightly from our prior outlook driven by higher results in Processing, but remain down from last year due to lower expected performance in Merchandising.

In Refined and Specialty Oils, full-year results are expected to be up from our prior outlook and in-line with last year's record performance.

In Milling, full-year results are expected to be lower than our prior outlook and significantly down from a strong prior year.

In Corporate and Other, results are expected to be in line with last year.

In Non-Core, full-year results in our sugar and bioenergy joint venture are expected to be in line

with last year.

Additionally, the Company expects the following for 2023: an adjusted annual effective tax rate in the range of 20% to 24%; net interest expense in the range of $350 to $370 million, which is down from our prior outlook of $360 to $390 million; capital expenditures in the range of $1.0 to $1.2 billion, which is up $200 million from our prior outlook, reflecting the purchase of a US oil refinery during the second quarter; and depreciation and amortization of approximately $415 million.


Ø			Conference Call and Webcast Details

Bunge Limited’s management will host a conference call at 8:00 a.m. Eastern (7:00 a.m. Central) on Wednesday, August 2, 2023 to discuss the Company’s results.

Additionally, a slide presentation to accompany the discussion of results will be posted on www.bunge.com.

To access the webcast, go to “Events & Presentations” under “News & Events” in the “Investor Center” section of the company’s website. Select “Q2 2023 Bunge Limited Conference Call” and follow the prompts. Please go to the website at least 15 minutes prior to the call to register and download any necessary audio software.

To listen to the call, please dial 1-844-735-3666. If you are located outside the United States or Canada, dial 1-412-317-5706. Please dial in five to 10 minutes before the scheduled start time. The call will also be webcast live at www.bunge.com.

A replay of the call will be available later in the day on August 2, 2023, continuing through September 2, 2023. To listen to it, please dial 1-877-344-7529 in the United States, 855-669-9658 in Canada, or 1-412-317-0088 in other locations. When prompted, enter confirmation code 2329170.


Ø			About Bunge

At Bunge (NYSE: BG), our purpose is to connect farmers to consumers to deliver essential food, feed and fuel to the world. With more than two centuries of experience, unmatched global scale and deeply rooted relationships, we work to strengthen global food security, increase sustainability where we operate, and help communities prosper. As the world’s leader in oilseed processing and a leading producer and supplier of specialty plant-based oils and fats, we value our partnerships with farmers to bring quality products from where they’re grown to where they’re consumed. At the same time, we collaborate with our customers to develop tailored and innovative solutions to meet evolving dietary needs and trends in every part of the world. Our Company is headquartered in St. Louis, Missouri, and we have almost 23,000 dedicated employees working across approximately 300 facilities located in more than 40 countries.


Ø			Website Information

We routinely post important information for investors on our website, www.bunge.com, in the "Investors" section. We may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, U.S. Securities and Exchange Commission ("SEC") filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.


Ø			Cautionary Statement Concerning Forward-Looking Statements

This press release contains both historical and forward-looking statements. All statements, other than statements of historical fact are, or may be deemed to be, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act). These forward-looking statements are not based on historical facts, but rather reflect our current expectations and projections about our future results, performance, prospects and opportunities. We have tried to identify these forward-looking statements by using words including “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “plan,” “intend,” “estimate,” “continue” and similar expressions. These forward-looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. The following important factors, among others, could cause actual results to differ from these forward-looking statements: the impact on our employees, operations, and facilities from the war in Ukraine and the resulting economic and other sanctions imposed on Russia, including the impact on Bunge resulting from the continuation and/or escalation of the war and sanctions against Russia; the effects of weather conditions and the impact of crop and animal disease on our business; the impact of global and regional economic, agricultural, financial and commodities market, political, social and health conditions; changes in government policies and laws affecting our business, including agricultural and trade policies, financial markets regulation and environmental, tax and biofuels regulation; the impact of seasonality; the impact of government policies and regulations; the outcome of pending regulatory and legal proceedings; our ability to complete, integrate and benefit from acquisitions, divestitures, joint ventures and strategic alliances, including without limitation Bunge's proposed business combination with Viterra Limited, and the Company's ability to consummate the proposed redomestication that would change the Company's place of incorporation and residence from Bermuda to Switzerland; the impact of industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products that we sell and use in our business, fluctuations in energy and freight costs and competitive developments in our industries; the effectiveness of our capital allocation plans, funding needs and financing sources; the effectiveness of our risk management strategies; operational risks, including industrial accidents, natural disasters, pandemics or epidemics and cybersecurity incidents; changes in foreign exchange policy or rates; the impact of our dependence on third parties; our ability to attract and retain executive management and key personnel; and other factors affecting our business generally. The forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.

You should refer to “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 24, 2023, “Risks Related to the Acquisition” and “Risks Related to the Redomestication” sections of the Company's preliminary proxy statement filed with the SEC on July 27, 2023.


Investor Contact: Ruth Ann Wisener Bunge Limited 636-292-3014 ruthann.wisener@bunge.com			Media Contact: Bunge News Bureau Bunge Limited 636-292-3022 news@bunge.com


Ø			Additional Financial Information

Certain gains and (charges), quarter-to-date

The following table provides a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on Net income (loss) attributable to Bunge, Earnings per share diluted and Segment EBIT for the three month periods ended June 30, 2023 and 2022.


(US$ in millions, except per share data)	Net Income (Loss) Attributable to Bunge				Earnings Per Share Diluted				Segment EBIT
Three Months Ended June 30,	2023		2022		2023		2022		2023		2022

Core Segments:	$	8	$	(58)	$	0.06	$	(0.37)	$	9	$	(68)
Agribusiness	$	8	$	(59)	$	0.06	$	(0.38)	$	9	$	(69)
Ukraine-Russia War	8		(59)		0.06		(0.38)		9		(69)




Refined and Specialty Oils	$	—	$	1	$	—	$	0.01	$	—	$	1

Ukraine-Russia War	—		1		—		0.01		—		1

Milling	$	—	$	—	$	—	$	—	$	—	$	—



Corporate and Other:	$	(42)	$	—	$	(0.28)	$	—	$	(34)	$	—
Impairment of equity method investment	(16)		—		(0.11)		—		(16)		—
Acquisition and integration costs	(26)		—		(0.17)		—		(18)		—

Non-core Segment:	$	—	$	—	$	—	$	—	$	—	$	—
Sugar & Bioenergy	$	—	$	—	$	—	$	—	$	—	$	—


Total	$	(34)	$	(58)	$	(0.22)	$	(0.37)	$	(25)	$	(68)

See Definition and Reconciliation of Non-GAAP Measures.

Core Segments

Agribusiness

EBIT for the three months ended June 30, 2023 included a mark-to-market gain of $9 million, in Cost of goods sold, related to inventory recovered from our Mykolaiv and other facilities in Ukraine. The circumstances allowing for recovery of these inventories did not exist and were unforeseeable when the inventory reserves were initially recorded in 2022 in conjunction with the Ukraine-Russia war.

EBIT for the three months ended June 30, 2022 included $69 million of charges, recorded in Cost of goods sold, resulting from the Ukraine-Russia war, primarily related to losses associated with inventories physically located in occupied territories in Ukraine, or in difficult to access locations with high costs of recovery.

Refined and Specialty Oils

EBIT for the three months ended June 30, 2022 included a reversal of $1 million of bad debt provisions, recorded in SG&A, previously recorded in conjunction with the Ukraine-Russia war but for which the underlying receivables were subsequently recovered.

Corporate and Other

EBIT for the three months ended June 30, 2023 included a $16 million impairment charge, in Income (loss) from affiliates, related to a minority investment in Australian Plant Proteins, a start-up manufacturer of novel protein ingredients.

Net income for the three months ended June 30, 2023 included $26 million of acquisition and integration costs (net of $3 million in tax benefits) related to the announced business combination agreement with Viterra. Specifically, the Company recorded $11 million of pre-tax charges within Interest expense for financing related fees, and $18 million of pre-tax charges within SG&A for other acquisition and integration related costs.

Certain gains and (charges), year-to-date



(US$ in millions, except per share data)	Net Income (Loss) Attributable to Bunge				Earnings Per Share Diluted				Segment EBIT
Six months ended June 30,	2023		2022		2023		2022		2023		2022

Core Segments:	$	16	$	(68)	$	0.11	$	(0.44)	$	19	$	(80)
Agribusiness	$	16	$	(68)	$	0.11	$	(0.44)	$	19	$	(80)
Ukraine-Russia Conflict	16		(68)		0.11		(0.44)		19		(80)



Refined and Specialty Oils	$	—	$	—	$	—	$	—	$	—	$	—




Milling	$	—	$	—	$	—	$	—	$	—	$	—


Corporate and Other:	$	(42)	$	(18)	$	(0.28)	$	(0.11)	$	(34)	$	29
Pension settlement	—		21		—		0.14		—		29
Bond early redemption	—		(39)		—		(0.25)		—		—
Impairment of equity method investment	(16)		—		(0.11)		—		(16)		—
Acquisition and integration costs	(26)		—		(0.17)		—		(18)		—

Non-core Segment:	$	—	$	—	$	—	$	—	$	—	$	—
Sugar & Bioenergy	$	—	$	—	$	—	$	—	$	—	$	—

Total	$	(26)	$	(86)	$	(0.17)	$	(0.55)	$	(15)	$	(51)

Core Segments

Agribusiness

EBIT for the six months ended June 30, 2023 included a mark-to-market gain of $19 million, in Cost of goods sold, related to inventory recovered from our Mykolaiv and other facilities in Ukraine. The circumstances allowing for recovery of these inventories did not exist and were unforeseeable when the inventory reserves were initially recorded in 2022 in conjunction with the Ukraine-Russia war.

EBIT for the six months ended June 30, 2022 included $80 million of charges, recorded in Cost of goods sold, resulting from the Ukraine-Russia war, primarily related to losses associated with inventories physically located in occupied territories in Ukraine, or in difficult to access locations with high costs of recovery.

Corporate and Other

EBIT for the six months ended June 30, 2023 included a $16 million impairment charge, in Income (loss) from affiliates, related to a minority investment in Australian Plant Proteins, a start-up manufacturer of novel protein ingredients.

Net income for the six months ended June 30, 2023 included $26 million of acquisition and integration costs (net of $3 million in tax benefits) related to the announced business combination agreement with Viterra. Specifically, the Company recorded $11 million of pre-tax charges within Interest expense for financing related fees, and $18 million of pre-tax charges within SG&A for other acquisition and integration related costs.

EBIT for the six months ended June 30, 2022 included a $29 million gain, at Bunge's 70% share, related to the settlement of one of the Company’s international defined benefit pension plans, recorded in Other income (expense) - net.

Net income for the six months ended June 30, 2022 also included $39 million of expense (net of $8 million in tax benefits) related to the early redemption of the Company's 4.350% unsecured senior notes due March 15, 2024. In connection with the early redemption, the Company recorded a $47 million pre-tax charge within Interest expense, comprising a $31 million "make-whole" payment and a $16 million loss on the termination and de-designation of related interest rate hedges.


Ø			Consolidated Earnings Data (Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
(US$ in millions, except per share data)	2023		2022		2023		2022
Net sales	$	15,049	$	17,933	$	30,377	$	33,813
Cost of goods sold	(13,684)		(17,161)		(27,831)		(31,837)
Gross profit	1,365		772		2,546		1,976
Selling, general and administrative expenses	(420)		(334)		(773)		(642)
Foreign exchange (losses) gains	(66)		(110)		(17)		(98)
Other income (expense) – net	12		(6)		27		(53)



Income (loss) from affiliates	25		20		44		65
EBIT attributable to noncontrolling interest (a) (1)	(4)		(20)		(29)		(33)
Total Segment EBIT	912		322		1,798		1,215
Interest income	40		11		83		20
Interest expense	(129)		(92)		(241)		(203)
Income tax (expense) benefit	(198)		(36)		(381)		(144)
Noncontrolling interest share of interest and tax (a) (1)	(3)		1		(5)		6


Net income (loss) attributable to Bunge (1)	$	622	$	206	$	1,254	$	894









Net income (loss) attributable to Bunge common shareholders - diluted	$	4.09	$	1.34	$	8.24	$	5.81
Weighted–average common shares outstanding - diluted	152		154		152		154


(a) The line items "EBIT attributable to noncontrolling interest" and "Noncontrolling interest share of interest and tax" when combined, represent consolidated Net (income) loss attributable to noncontrolling interests on a U.S. GAAP basis of presentation.


Ø			Condensed Consolidated Balance Sheets (Unaudited)


	June 30,		December 31,
(US$ in millions)	2023		2022
Assets
Cash and cash equivalents	$	1,330	$	1,104

Trade accounts receivable, net	2,599		2,829
Inventories (a)	8,806		8,408
Assets held for sale	—		36
Other current assets	4,465		4,381
Total current assets	17,200		16,758
Property, plant and equipment, net	4,152		3,617
Operating lease assets	951		1,024
Goodwill and other intangible assets, net	830		830
Investments in affiliates	1,157		1,012

Other non-current assets	1,422		1,339
Total assets	$	25,712	$	24,580

Liabilities and Equity
Short-term debt	$	667	$	546
Current portion of long-term debt	4		846

Trade accounts payable	4,248		4,386
Current operating lease obligations	370		425
Liabilities held for sale	—		18
Other current liabilities	3,002		3,379
Total current liabilities	8,291		9,600
Long-term debt	4,278		3,259
Non-current operating lease obligations	529		547
Other non-current liabilities	1,252		1,214
Total liabilities	14,350		14,620
Redeemable noncontrolling interest	4		4
Total equity	11,358		9,956
Total liabilities, redeemable noncontrolling interest and equity	$	25,712	$	24,580

(a) Includes readily marketable inventories of $7,196 million and $6,654 million at June 30, 2023 and December 31, 2022, respectively. Assets held for sale includes RMI of zero and $26 million at June 30, 2023 and December 31, 2022, respectively. Of the total RMI, $5,898 million and $4,789 million can be attributable to merchandising activities at June 30, 2023 and December 31, 2022, respectively.


Ø			Condensed Consolidated Statements of Cash Flows (Unaudited)


	Six Months Ended June 30,
(US$ in millions)	2023		2022
Operating Activities
Net income (loss) (1)	$	1,288	$	921
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Impairment charges	22		—
Foreign exchange (gain) loss on net debt	(174)		(6)
Depreciation, depletion and amortization	208		204
Deferred income tax expense (benefit)	67		(59)
(Gain) loss on sale of investments and property, plant and equipment	(3)		—
Results from affiliates	(61)		(65)
Other, net	90		133
Changes in operating assets and liabilities, excluding the effects of acquisitions:
Trade accounts receivable	290		(341)
Inventories	(195)		(2,341)
Secured advances to suppliers	(11)		46
Trade accounts payable and accrued liabilities	(605)		943
Advances on sales	(220)		(54)
Net unrealized (gain) loss on derivative contracts	(262)		(159)
Margin deposits	(22)		(86)
Recoverable and income taxes, net	(87)		(152)
Marketable securities	36		285
Beneficial interest in securitized trade receivables (a)	—		(3,443)
Other, net	111		(283)
Cash provided by (used for) operating activities	472		(4,457)
Investing Activities
Payments made for capital expenditures	(541)		(212)

Proceeds from investments	14		87
Payments for investments	(20)		(117)
Settlement of net investment hedges	(48)		(143)
Proceeds from beneficial interest in securitized trade receivables (a)	79		3,311

Proceeds from sales of businesses and property, plant and equipment	162		1

Payments for investments in affiliates	(130)		(54)
Other, net	100		(6)
Cash provided by (used for) investing activities	(384)		2,867
Financing Activities
Net borrowings (repayments) of short-term debt	149		1,576
Net proceeds (repayments) of long-term debt	99		(578)
Proceeds from the exercise of options for common shares	4		44

Dividends paid to common and preference shareholders	(188)		(162)

Contributions from (Return of capital to) noncontrolling interest	33		—
Sale of noncontrolling interest	—		521

Other, net	(5)		44
Cash provided by (used for) financing activities	92		1,445
Effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale	28		63
Net increase (decrease) in cash and cash equivalents, restricted cash, and cash held for sale	208		(82)
Cash and cash equivalents, restricted cash, and cash held for sale - beginning of period	1,152		905
Cash and cash equivalents, restricted cash, and cash held for sale - end of period	$	1,360	$	823

(a) See Quarter Results, Cash Flow Section for details regarding changes to the trade receivables securitization program.


Ø			Definition and Reconciliation of Non-GAAP Measures

This earnings release contains certain "non-GAAP financial measures" as defined in Regulation G of the Securities Exchange Act of 1934. Bunge has reconciled these non-GAAP financial measures to the most directly comparable U.S. GAAP measures below. These measures may not be comparable to similarly titled measures used by other companies.

Total Segment EBIT and Adjusted Total Segment EBIT

Bunge uses segment earnings before interest and tax (“Segment EBIT”) to evaluate the operating performance of its individual segments. Segment EBIT excludes EBIT attributable to noncontrolling interests. Bunge also uses Core Segment EBIT, Non-Core Segment EBIT, Corporate and Other EBIT and Total Segment EBIT to evaluate the operating performance of Bunge’s Core reportable segments, Non-Core reportable segments, and Total reportable segments together with its Corporate and Other activities, respectively. Core Segment EBIT is the aggregate of the earnings before interest and taxes of each of Bunge’s Agribusiness, Refined and Specialty Oils, and Milling segments. Non-Core Segment EBIT is the earnings before interest and taxes of Bunge’s Sugar & Bioenergy segment. Total Segment EBIT is the aggregate of the earnings before interest and taxes of Bunge’s Core and Non-Core reportable segments, together with its Corporate and Other activities.

Adjusted Core Segment EBIT, Adjusted Non-Core Segment EBIT, Adjusted Corporate and Other EBIT and Adjusted Total Segment EBIT, are calculated by excluding temporary mark-to-market timing differences, as defined in note 3 below, and certain gains and (charges), as described in "Additional Financial Information" above, from Core Segment EBIT, Non-Core Segment EBIT, Corporate and Other EBIT, and Total Segment EBIT, respectively.

Core Segment EBIT, Non-Core Segment EBIT, Corporate and Other EBIT, Total Segment EBIT, Adjusted Core Segment EBIT, Adjusted Non-core Segment EBIT, Adjusted Corporate and Other EBIT and Adjusted Total Segment EBIT are non-GAAP financial measures and are not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Bunge's management believes these non-GAAP measures are a useful measure of its reportable segments' operating profitability, since the measures allow for an evaluation of segment performance without regard to their financing methods or capital structure. For this reason, operating performance measures such as these non-GAAP measures are widely used by analysts and investors in Bunge's industries. These non-GAAP measures are not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss) or any other measure of consolidated operating results under U.S. GAAP.

Net Income (loss) attributable to Bunge to Adjusted Net Income (loss) attributable to Bunge

Adjusted Net Income (loss) excludes temporary mark-to-market timing differences, as defined in note 3 below, and certain gains and (charges), as described in "Additional Financial Information" above, and is a non-GAAP financial measure. This measure is not a measure of Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. It should not be considered as an alternative to Net Income (loss) attributable to Bunge, Net Income (loss), or any other measure of consolidated operating results under U.S. GAAP. Adjusted Net income (loss) is a useful measure of the Company's profitability.

We also have presented projected Adjusted Net income per common share for 2023. This information is provided only on a non-GAAP basis without reconciliation to projected Net Income per common share for 2023, the mostly directly comparable U.S. GAAP measure. The most directly comparable GAAP measure has not been provided due to the inability to quantify certain amounts necessary for such reconciliation, including but not limited to potentially significant future market price movements over the remainder of the year.

Below is a reconciliation of Net income attributable to Bunge, to Total Segment EBIT, and Adjusted Total Segment EBIT:


	Three Months Ended June 30,				Six Months Ended June 30,
(US$ in millions)	2023		2022		2023		2022
Net income (loss) attributable to Bunge	$	622	$	206	$	1,254	$	894
Interest income	(40)		(11)		(83)		(20)
Interest expense	129		92		241		203
Income tax expense (benefit)	198		36		381		144

Noncontrolling interest share of interest and tax	3		(1)		5		(6)
Total Segment EBIT	$	912	$	322	$	1,798	$	1,215

Agribusiness EBIT	$	785	$	93	$	1,490	$	792
Refined and Specialty Oils EBIT	217		218		450		$	391
Milling EBIT	14		97		23		$	147
Core Segment EBIT	$	1,016	$	408	$	1,963	$	1,330

Corporate and Other EBIT	$	(155)	$	(92)	$	(235)	$	(155)

Sugar & Bioenergy EBIT	$	51	$	6	$	70	$	40
Non-Core Segment EBIT	$	51	$	6	$	70	$	40

Total Segment EBIT	$	912	$	322	$	1,798	$	1,215
Mark-to-market timing difference	(114)		233		(295)		157
Certain (gains) & charges	25		68		15		51
Adjusted Total Segment EBIT	$	823	$	623	$	1,518	$	1,423

Below is a reconciliation of Net income (loss) attributable to Bunge, to Adjusted Net income (loss) attributable to Bunge:


	Three Months Ended June 30,				Six Months Ended June 30,
(US$ in millions, except per share data)	2023		2022		2023		2022
Net income (loss) attributable to Bunge	$	622	$	206	$	1,254	$	894
Mark-to-market timing difference	(89)		194		(217)		132
Certain (gains) and charges:
Ukraine-Russia war	(8)		58		(16)		68
Pension settlement	—		—		—		(21)
Bond early redemption	—		—		—		39

Impairment of equity investments	16		—		16		—






Acquisition and integration costs	26		—		26		—







Adjusted Net income (loss) attributable to Bunge	$	567	$	458	$	1,063	$	1,112
Weighted-average common shares outstanding - diluted, adjusted (a)	152		154		152		154
Adjusted Net income (loss) per common share - diluted	$	3.72	$	2.97	$	6.98	$	7.23

(a) There were less than 1 million anti-dilutive outstanding stock options or contingently issuable restricted stock units excluded in the weighted-average number of common shares outstanding for each of the three and six month periods ended June 30, 2023 and 2022.

Adjusted Funds From Operations and Cash provided by (used for) operating activities, adjusted

Adjusted FFO is calculated by excluding from Cash provided by (used for) operating activities, foreign exchange gain (loss) on net debt, payments for beneficial interests in securitized trade receivables, working capital changes, net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests, and mark-to-market timing differences after tax. Adjusted FFO is a non-GAAP financial measure and is not intended to replace Cash provided by (used for) operating activities, the most directly comparable U.S. GAAP financial measure. Bunge management believes presentation of this measure allows investors to view its cash generating performance using the same measure that management uses in evaluating financial and business performance and trends without regard to foreign exchange gains and losses, working capital changes and mark-to-market timing differences. This non-GAAP measure is not a measure of consolidated cash flow under U.S. GAAP and should not be considered as an alternative to Cash provided by (used for) operating activities, Net increase (decrease) in cash and cash equivalents, restricted cash, and cash held for sale, or any other measure of consolidated cash flow under U.S. GAAP.

Cash provided by (used for) operating activities, adjusted is calculated by including the Proceeds from beneficial interests in securitized trade receivables with Cash provided by (used for) operating activities. Cash provided by (used for) operating activities, adjusted is a non-U.S. GAAP financial measure and is not intended to replace Cash provided by (used for) operating activities, the most directly comparable U.S. GAAP financial measure. Our management believes presentation of this measure allows investors to view our cash generating performance using the same measure that management uses in evaluating financial and business performance and trends.


Ø			Notes

(1) A reconciliation of Net income (loss) attributable to Bunge, to Net income (loss) is as follows:


	Three months ended June 30,				Six months ended June 30,
(US$ in millions)	2023		2022		2023		2022
Net income (loss) attributable to Bunge	$	622	$	206	$	1,254	$	894
EBIT attributable to noncontrolling interest	4		20		29		33
Noncontrolling interest share of interest and tax	3		(1)		5		(6)
Net income (loss)	$	629	$	225	$	1,288	$	921

(2) The Processing business included in our Agribusiness segment consists of: global oilseed processing activities, which principally include the origination and crushing of oilseeds (including soybeans, canola, rapeseed and sunflower seed) into protein meals and vegetable oils; the distribution of oilseeds, oilseed products and fertilizer products through our port terminals and transportation assets (including trucks, railcars, barges and ocean vessels); fertilizer production; and biodiesel production, which is partially conducted through joint ventures.

The Merchandising business included in our Agribusiness segment primarily consists of: global grain origination activities, which principally include the purchasing, cleaning, drying, storing and handling of corn, wheat and barley at our network of grain elevators; logistical services for the distribution of these commodities to our customer markets through our port terminals and transportation assets (including trucks, railcars, barges and ocean vessels); and financial services activities for customers from whom we purchase commodities, and other third parties.

(3) Mark-to-market timing difference comprises the estimated net temporary impact resulting from unrealized period-end gains/losses associated with the fair valuation of certain forward contracts, readily marketable inventories (RMI), and related futures contracts associated with our committed future operating capacity. The impact of these mark-to-market timing differences, which is expected to reverse over time due to the forward contracts, RMI, and related futures contracts being part of an economically-hedged position, is not representative of the operating performance of our business.

(4) A reconciliation of Cash provided by (used for) operating activities to Adjusted funds from operations (FFO) is as follows:


	Six months ended June 30,
(US$ in millions)	2023		2022
Cash provided by (used for) operating activities	$	472	$	(4,457)
Foreign exchange gain (loss) on net debt	174		6
Beneficial interest in securitized trade receivables	—		3,443
Working capital changes	965		2,142
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests	(34)		(27)
Mark-to-Market timing difference, after tax	(217)		132
Adjusted FFO	$	1,360	$	1,239

(5) We have not presented a comparable U.S. GAAP financial measure for any full-year 2023 outlook financial measures presented on an adjusted, non-GAAP basis because the information necessary for such presentation is unavailable at this time. The information necessary to prepare the comparable U.S. GAAP presentation could result in significant differences from the non-GAAP financial measures presented in this release. Please see “Definition and Reconciliation of Non-GAAP Measures” for more information.